In clinical practice the treatment of lactose are unresolved problem and are relevant. The correct choice of tactics and comprehensive treatment provide not only the elimination of stagnation of milk, but also ensure the prevention of lactational mastitis. The use of complex measures, change the multiplicity and rules of lactation, namely: feeding by means of two breasts every 1.5-2 hours, if necessary – every hour – are effective in the treatment of lactosis. To eliminate the stagnation of milk it is necessary to use heat, gentle massage of the breast, pumping, including the use of a breast pump. Pumping milk residues should be up feelings of comfort in the breast. The main component of lactosis therapy is the use of drugs. The use of drugs which affect the reduction of prolactin levels (dostinex, parlodel) with preparations that improve the flow of milk (progestogel, oxytocin) is optimal in therapy. Combined use of dostinex with oxytocin in combination with therapeutic interventions is more effective and fast therapy. Only an integrated approach allows to achieve a therapeutic effect on condition of ensuring monitoring of devel-opment of pathological process and an exception of development of mastitis. In the absence of expected effect within a day it is necessary to carry out careful differential and diagnostic procedure for exceptions lactational mastitis, including repeated breast ultrasound and needle biopsy by means of thick needle.

Lactose is a consequence of dysfunction of the mammary glands in women with breastfeeding between production and secretion of milk, resulting in stagnation of milk. The purpose is to study predisposing anatomical and physiological factors in the de-velopment of lactose associated with narrowing of the ducts and hypofunction lobular-ductal system of the breast in women with breastfeeding. The research has included a study of the status of the lactating breast in 42 women with breastfeeding. The 1st group consisted of 27 women with lactose. Control (the 2nd) group consisted of 15 women with breastfeeding without lactose. The study has shown that the development of the stagnation of milk is caused by a range of predisposing and contributing factors, among which the most important are the anatomical and physiological reasons: the restriction and paresis of the milk ducts, dyscoordination of the lobular-ductal system. The leading cause of stagnation of milk is an anatomical narrowing and the tortuous course of the milky threads with physiological dysfunction of the ductal system of the lactating breast. A main factor in the development of the pathological process is fibrocystic breast disease, which is characterized by morphological and functional changes in the mammary glands in the form of diffuse or focal changes of the connective tissue, mainly ductectasia. These changes under effects of other factors on a certain area of the lactating mammary glands lead either to morpho-functional narrowing, the violation of the ducts, either individual or combined physiological hypofunctions of up to paresis. Appeared first sections of the stagnation of milk, swelling of the breast increase the compression duct and obstruct the outflow of milk, leading to clinically significant pathological process of the lactose, the resolution of which requires consideration of all the above clinical and pathogenetic data with a complex of therapeutic measures.

The actual problem of lactostasis in breast feeding is considered in this paper.The main causes of lactostasisare: excessive milk production at insufficient milk secretion from the lobules of the mammary glands; irregular and inadequate emptying of the breast, not correct attachment of the baby to the breast, i.e. not all lobules are equal "physiological” position. The authors considered predisposing factors of lactose in the first days after birth and active breastfeeding, as well as the development of tactics pathogenetic therapy. The work is based on the study of data examination and treatment of 39 patients with lactose, divided into 2 groups. In the first group the treatment consisted of local use of 1% progestogel; in the 2nd group - bromocriptine in tablets. The study showed that lactosis is especially typical for primapara women and for the first (1-2) months after delivery. The lactosis in the first days after delivery are more associated with impaired excretion of milk due to the low content of oxytocin and smooth muscle paresis ducts, this is confirmed by the effect of transdermal gel 1% progestogel. At other times one of the causes of lactosis is increased production or sufficient production of milk when it is insufficient excretion through milk ducts. The effect of bromocriptine in such cases is due to a reduc-tion of milk production in accordance with the ability of the system excretion of milk.